Table 1. DA sample recovery. As part of our ongoing effort to innovate scientific research, we have effectively created a novel approach to dopamine (DA) detection using the CRISPR/Cas12 gene editing ...

Nov. 6, 2024 — The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease. However, researchers have now shown that there is a ...

近日，复旦大学王永明教授与东南大学柴人杰教授联合团队在Science Bulletin上发表题为“Discovery and engineering of ChCas12b for precise genome ...

A pipeline for the analysis of CRISPR edited data. It allows the evaluation of the quality of gene editing experiments using targeted next generation sequencing (NGS) data (`targeted`) as well as the ...

After hours: November 29 at 4:58 PM EST Loading Chart for CRSP ...

On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. After all, it's been less than a year since regulators in the U.S. and E.U. approved its ...

CRISPR-Cas基因编辑技术在基础研究 ... Cas蛋白作为该系统的核心组件，除了广为人知的II型Cas9蛋白外，V型Cas12家族（如Cas12a至Cas12n）也逐渐被发掘。

【导读】 就在刚刚，AI设计DNA、RNA和蛋白质序列的能力再获得颠覆性突破，研究登上Science封面。Evo模型能以无与伦比的准确性，解码和设计从分子到基因组规模的对象了，合成生物学的工作方式，从此或将彻底颠覆。

The CRISPR molecular scissors have the potential to revolutionize the treatment of genetic diseases. This is because they can be used to correct specific defective sections of the genome.